PDB28 THE COST-EFFECTIVENESS ANALYSIS OF VIDALGLIPTIN IN TYPE 2 DIABETES IN POLAND

Autor: Walczak, J, Nogas, G, Gebus, E, Pawlik, D, Pacocha, K
Zdroj: In Value in Health 2009 12(7):A406-A406
Databáze: ScienceDirect